Publications

Select keywords to filter the posts for matching content:

Keywords
Topics
  • TAURUS-MS II: real-world use of teriflunomide in Germany and changes in treatment patterns over time
    Boris-Alexander Kallmann, Georg zu Eulenburg, Jennifer S. Kullmann, Mathias Mäurer
    PMID: 10.1177/17562864241252722 Show Details link to full text
    Study

    TAURUS-MS II

    Year

    2024

    Keywords
  • InspeCKD - Analysis of the use of diagnostics in patients at high risk for chronic kidney disease in German general practitioner (GP) practices
    Christoph Wanner, Elke Schaeffner, Thomas Frese, Christoph Weber, Philipp Stahl, Felix Scherg, Fabian Burckhardt, Ulrich Opfermann, Frank Radowsky, Frederik Mader
    PMID: 10.1007/s15006-024-3684-y Show Details link to full text
    Study

    inspeCKD

    Year

    2024

    Keywords
    • CKD
  • New Systemic Therapy Strategies for HER2-Positive Metastatic Breast Carcinoma
    Maggie Banys-Paluchowski
    PMID: 10.1055/a-1850-9512 Show Details link to full text
    Study

    Year

    2023

    Keywords
    • HER2
    • breast cancer
  • Breast Cancer and Genetic BRCA1/2 Testing in Routine Clinical Practice: Why, When and For Whom?
    Michael P. Lux, Peter A. Fasching
    PMID: 10.1055/a-1929-2629 Show Details link to full text
    Study

    Year

    2023

    Keywords
    • breast cancer
  • Incidental Pulmonary Nodules - What Do We Know in 2022
    Gerald Schmid-Bindert, Jens Vogel-Claussen, Sylvia Gütz, Joana Fink, Hans Hoffmann, Martin E. Eichhorn, Felix J.F. Herth
    Study

    Year

    2022

    Keywords
    • lung cancer
  • A Prospective Study to Evaluate the Impact of Golimumab Therapy on Work Productivity and Activity, and Quality of Life in Patients with Rheumatoid Arthritis, Psoriasis Arthritis and Axial Spondyloarthritis in a Real Life Setting in AUSTRIA. The GO-ACTIVE
    C. Dejaco, T. Mueller, O. Zamani, U. Kurtz, S. Egger, J. Resch-Passini, A. Totzauer, B. Yazdani-Biuki, T. Schwingenschloegl, P. Peichl, A. Kraus, G. W. Naerr
    Study

    GO ACTIVE

    Year

    2022

    Keywords
    • rheumatoid arthritis
    • psoriatic arthritis
    • axial spondyloarthritis
    • golimumab
    • QoL
    • WPAI
  • Prognostic relevance of the HER2 status of circulating tumor cells in metastatic breast cancer patients screened for participation in the DETECT study program.
    V. Müller, M. Banys-Paluchowski, T.W.P. Friedl, P.A. Fasching, A. Schneeweiss, A. Hartkopf, D. Wallwiener, B. Rack, F. Meier-Stiegen, J. Huober, M. Rübner, O. Hoffmann, L. Müller, W. Janni, P. Wimberger, B. Jäger, K. Pantel, S. Riethdorf, N. Harbeck, T. Fehm, DETECT study group
    Study

    DETECT

    Year

    2021

    Keywords
    • breast cancer
    • liquid biopsy
    • HER2
    • oncology
  • Golimumab improves work productivity in patients suffering from moderate to severe ulcerative colitis: results of a prospective study over 24 months.
    N. Teich, H. Grümmer, E. Jörgensen, T. Liceni, F. Holtkamp-Endemann, T. Fischer, S. Hohenberger
    Study

    Go CUTE II

    Year

    2021

    Keywords
    • golimumab
    • ulcerative colitis
    • QoL
    • WPAI
    • HCRU
  • Effect of Originator Infliximab Treatment on Disease-Related Hospitalizations, Work Productivity and Activity Impairment, and Health Resource Utilization in Patients with Crohn's Disease in a Real-Life Setting: Results of a Prospective Multicenter Study i
    N. Teich, M. Bläker, F. Holtkamp-Endemann, E. Jörgensen, A. Stallmach, S. Hohenberger
    Study

    MC Productive

    Year

    2021

    Keywords
    • Crohn's disease
    • infliximab
    • QoL
    • WPAI
    • HRQoL
  • Neoadjuvant and adjuvant end-points in health technology assessment in oncology.
    N. Harbeck, A. Schneeweiss, P. Thuss-Patience, K. Miller, C. Garbe, F. Griesinger, W. E. E. Eberhardt, J. P. Klussmann, B. Wollenberg, M. O. Grimm, T. Zander, D. Lüftner
    Study

    AMNOG

    Year

    2021

    Keywords
    • immunotherapy
    • oncology
Follow:
Seite: 1/5